IL1B and arthritic joint disease: Traditional arthritis treatments that include steroids, non-steroidal anti-inflammatory drugs (NSAIDs), and biological agents such as antagonists of TNF-α and interleukin-1 beta (IL-1β) have limited efficacies and are associated with several unpleasant side effects (Ahmed et al., 2005).